ARVO 2024: New research indicates the need for a new approach to central vision loss
Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care
ARVO 2024: Updates from the BLINK2 study on contact lens wear and axial length growth
At this year's ARVO meeting, new data from the BLINK2 study show axial growth rates after discontinuing soft multifocal contact lens wear
ARVO 2024: How delayed onset of vision impairment alters auditory distance estimation
Age of vision loss onset has a stark impact on patients’ auditory processing and sensory substitution
ARVO 2024: Murine model of multiple sclerosis demonstrates correlation between visual markers and motor-sensory deficits
Study data demonstrated a significant correlation between visual function, structure and neurological impairment in an experimental autoimmune encephalomyelitis model
ASCRS 2024: Dr Richard Lindstrom encourages ophthalmologists of all ages to get involved with YES
Dr Richard Lindstrom speaks about the future of dry eye and shares pearls for young eye surgeons
ARVO 2024: Industry leaders will provide company updates and new clinical data at conference
Ahead of the meeting, several companies previewed product pipeline announcements and research data presentations
Plan your visit to Seattle: This year's ARVO meeting promises must-see programming
The meeting kicks off with symposia and an opening keynote speech from Ed Yong
May is Inherited Retinal Disease Genetic Testing Awareness Month, Prevent Blindness expands on previous weeklong campaign
During the month of May, Prevent Blindness will offer fact sheets, videos and other resources for IRD education
TEASE-3 study: Positive interim data are reported for Stargardt drug
Gildeuretinol halts Stargardt disease progression, study results indicate
Interactive vision simulator illustrates the vision loss caused by retinal diseases
The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases
Retina community mourns sudden loss of Ramin Tadayoni, MD, PhD
Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President
Amniotic membrane could move the needle outside of the operating room
The tissue serves as a testing ground for outpatient ocular therapies
ASCRS 2024: MIGS data is outpacing "human intelligence," driving calls for AI
David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space
Clinicians and researchers don’t shy away from hot topics in the field
The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece
ASCRS 2024: Real-world results with an enhanced monovision toric lens
Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens
ASCRS 2024: First-in-human data from Centricity Vision's ZEPTOLink IOL positioning system
The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event
I-SCREEN programme will use AI and OCT imaging to identify and monitor AMD
I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast
ASCRS 2024: Two papers demonstrate medication burden reduction and safety of a microcatheter for glaucoma
Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston
ASCRS 2024: A case report on human corneal endothelial cell transplantation combined with cataract extraction and PCIOL
Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024
ASCRS 2024: A retrospective study shows iStent's impact on medication burden in surgical and non-surgical patient groups
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
ASCRS 2024: Pearls of clinical and non-clinical wisdom for young eye surgeons
At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme
ASCRS 2024: IOLs, binocularity and stereoacuity in aperture optics
William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity
ASCRS 2024: Transforming how we think about IOL calculation with Light Adjustable Lens technology
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
ASCRS 2024: Comparing keratometry and total keratometry values in a large dataset
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
ASCRS 2024: What's new in the ESCRS IOL calculator?
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
ASCRS 2024: At Eyecelerator, a New Zealand-based startup pitches eye drops for keratoconus
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
ASCRS 2024: Surgical and pharmaceutical technology updates from Bausch + Lomb
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
ASCRS 2024: Ease of opening arcuate incisions created with a dual pulse femtosecond laser
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
